Pershing and Valeant Settle Allergan Lawsuits

05.01.2018 - Pershing Square, the hedge fund of US activist investor Bill Ackman, and Canada-based drugmaker Valeant Pharmaceuticals have agreed in principle to pay $290 million to settle two...